Trial 114-NH-301

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

114-NH-301

Full title

A phase III, randomized, double-blind study of galiximab in combination with rituximab compared with rituximab in combination with placebo for the treatment of subjects with relapsed or refractory, follicular Non Hodgkin's lymphoma.

EudraCT number

2005-003836-22

NCT number

NCT00363636

Responsible organization

KUM - Med3 - Medizinische Klinik und Poliklinik III Lmu

Indications

Classification	Code	Description
ICD-10-GM	C81-C96	Bösartige Neubildungen des lymphatischen, blutbildenden und verwandten Gewebes, als primär festgestellt oder vermutet

Trial design

Trial type

Interventional

Phase

III

Status

Recruitment finished

Votes

Institutional review board - vote

Positive

Initiiation & lock

Date of lock (planned / actual)

Unknown / Unknown

Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.